Chemed CHE
NYSE CHE
$524.42 +0.43 (+0.08%)
As of: Sep 3, 2026 · 3:59 PM EDT

Chemed (CHE) EBITDA Margin Growth (3y) (2012 - 2026)

Analysis

Chemed (CHE) EBITDA Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 HCA Healthcare 90.36 Bn 89.35 Bn 15.19 Bn -482.00
2 Tenet Healthcare 22.02 Bn 19.85 Bn 4.45 Bn 1,479.00
3 Encompass Health 12.13 Bn 11.99 Bn 1.34 Bn 115.00
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn 278.00
5 Universal Health Services 10.09 Bn 9.95 Bn 3.29 Bn 324.00
6 Ensign 9.97 Bn 9.65 Bn 306.24 Mn 5.00
7 Chemed 6.93 Bn 6.89 Bn 221.47 Mn 54.00
8 Pacs 6.81 Bn 6.64 Bn 338.46 Mn 114.00
9 Concentra Group Holdings Parent 4.32 Bn 4.16 Bn 192.10 Mn 141.00
10 Option Care Health 3.74 Bn 3.55 Bn 267.25 Mn -182.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.00
Mar 31, 2026 -15.00
Dec 31, 2025 81.00
Sep 30, 2025 -352.00
Jun 30, 2025 -648.00
Mar 31, 2025 -241.00
Dec 31, 2024 -44.00
Sep 30, 2024 -207.00
Jun 30, 2024 97.00
Mar 31, 2024 -294.00
Dec 31, 2023 -75,419.00
Sep 30, 2023 138.00
Jun 30, 2023 -596.00
Mar 31, 2023 -240.00
Dec 31, 2022 2,337.00
Sep 30, 2022 205.00
Jun 30, 2022 377.00
Mar 31, 2022 632.00
Dec 31, 2021 2,616.00
Sep 30, 2021 337.00